drugset / Trial / NCT03860597
Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia
RandomizedCrossoverDouble-blindSupportive care
Summary
This application seeks to determine if neurophysiological metrics of memantine (MEM)-enhanced early auditory information processing (EAIP) in schizophrenia (SZ) mediate gains in auditory processing fidelity (APF) and auditory learning.
Timeline
- Start
- 2018-04-01
- Primary completion
- 2021-03-31
- Completion
- 2021-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Memantine | Unknown | 20 mg | Oral |